StockData
Avenue Therapeutics, Inc. logo

Avenue Therapeutics, Inc. (ATXI) stock

ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$0.43+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.42MP/E –Yield –

Avenue Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Avenue Therapeutics's profit margin for the twelve months ending Dec 31, 2025 was -207.2%. For fiscal 2025 it was -207.2%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-207.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2025Jun 30, 202523.9%–

More Avenue Therapeutics figures

See a number that looks wrong?